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Abstract Results
The work presented here was funded by the University of Minnesota UROP. Experiments reported in this poster were
performed at the Biophysical Technology Center, University of Minnesota Department of Biochemistry, Molecular Biology,
and Biophysics.
In previous experiments it was shown that when the N-terminus of b-III-spectrin, a
~50 residue disordered region, was truncated b-III-spectrin lost all binding affinity to
actin1. We performed binding studies in the form of actin co-sedimentation
experiments to determine if the N-terminus of b-III-spectrin alone in the form of a
synthetic peptide binds to actin and, if so, how much it contributed to the actin-
spectrin interaction. We found that the N-terminus does bind to actin; however, a
consistent Kd has yet to be determined. The co-sedimentation experiments were
systemically adjusted in an attempt to improve the consistency of the calculated Kd.
The major attempts at improving the results were increasing the starting
concentration of the N-terminal peptide for each sample, incorporating use of a
standard curve using different concentrations of the N-terminal peptide to determine
the percent bound to actin, and preparing F-actin the same day as the experiment.
Another way to check if the N-terminus does indeed contribute to the b-III-
spectrin/actin interaction is to use EPR (electron paramagnetic resonance) to
determine the conformation of the N-terminus in the presence of actin. To perform
this experiment new cysteines must be mutated into the N-terminus sequence while
other naturally occurring cysteines must be mutated out. In this way, the spin labels
only attach to the N-terminus and not the ABD. These mutations are still in
progress. To better understand possible structures of the N-terminus in relation to
binding, we began using the computer simulation program NAMD (Nanoscale
Molecular Dynamics). Thus far, the N-terminus has shown that helical structures are










1. Using actin co-sedimentation experiments it was determined that the N-terminus of
b-III-spectrin binds to actin in isolation of the ABD.
2. Possible N-terminus secondary structures are being simulated in an attempt to help
visualize how it would contribute to the actin-spectrin interaction.
3. From these simulations it appears that the N-terminus may not be completely
disordered when it is not in the presence of actin.
4. EPR will be used to determine if the N-terminus forms a stable conformer when
bound to actin once the proper mutations are made.
5. Ultimately, these results will help us figure out a way to partially block the mutated
β-III-spectrin2 to attenuate its pathologically high actin affinity.
Actin Co-sedimentation – For the co-sedimentations each sample contained 15 or
20µM of the N-terminus (in isolation of the ABD) while the actin concentration in
each sample varied. After mixing the actin and peptide the samples were incubated
at room temperature for 30 minutes before being spun down allowing the actin (and
any peptide that bound to the actin) in each sample to form a pellet. The
supernatant from the samples were run on a gel and the intensities of the peptide
bands were recorded.
Data Analysis - In Microsoft Excel the data from the cosedimentations was
analyzed by comparing the peptide concentrations to a standard curve and by using
the following fit equation 𝑩𝒎𝒂𝒙 ∗ 𝑨𝒄𝒕𝒊𝒏𝑲𝒅 + [𝑨𝒄𝒕𝒊𝒏]
These fitting parameters along with using Solver in Excel to minimize the sum of
square errors between the data and the fit provided the maximal binding capacity
(Bmax ) and binding affinity (Kd).
Computer Simulation - NAMD with the force field CHARMM36 was used to collect
data about the N-terminus in an implicit solvent. The software VMD (Visual
Molecular Dynamics) was used to analyze this data and determine secondary
structure probabilities for each residue in the sequence.
Methods
Figure 1. Binding curve from 9/11/17 for the N-
terminus of b-III-spectrin. Each sample initially had a
peptide concentration of 15µM. An equilibrium
dissociation constant of 124µM was found.
Figure 2. Gel from 9/11/17 co-sedimentation. Each
sample initially contained 15µM of the peptide. It can
be observed that the concentration of the peptide
decreased while the actin concentration was
increased. However, given how faint the bands
became it was decided to increase the initial
concentration of the peptide to 20µM.
Figure 3. Binding curve from 10/16/17. In an
attempt to optimize the results a standard curve
using varying concentrations of the peptide was run
on a separate gel. This curve was used to directly
relate the intensity of the peptide band to the
peptide concentration. The ten samples were also
run across two gels allowing for a space between
each sample.
Co-sedimentation of β-III-Spectrin IDR
Cryo-EM based structural model for b-III-spectrin ABD (multiple
colors) bound to actin (light blue). The N-terminus for each b-III-
spectrin is denoted in black. Note that the CH2 domain is not
visible since it is disordered.
Figure 4. Secondary structure probability for each
residue in the N-terminus. Probabilities are
determined from 110ns of simulated time using the
computer program NAMD. The probability for
becoming helical was calculated by adding the
probability for becoming an alpha and 3-10 helix.
Figure 5. Highlighting helical probability specifically
for each residue in the N-terminus. Probabilities are
determined from 110ns of simulated time using the
computer program NAMD.
Figure 9. Cysteines located in the
actin binding domain of b-III-spectrin.
Region that 
is helical in 
cryo-EM
My hypotheses are that the N-terminus contributes
significantly to the actin-spectrin interaction and




Figure 7. Conformation of the β-III-
spectrin N-terminus derived from
simulation. Region that is helical in
modeled cryo-EM structure does
have some helix structure in the
absence of actin (black residues).
Figure 8. Sequencing results for the
C231S mutation. The asterisk
indicates the nucleotide that was
changed (thymine to adenine).
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